Gq/11-induced and spontaneous waves of coordinated network activation in developing frontal cortex.
Repeated episodes of spontaneous large-scale neuronal bursting and calcium influx in the developing brain can potentially affect such fundamental processes as circuit formation and gene expression. Between postnatal day 3 (P3) and P7, the immature cortex can express one such form of activation whereby a wave of neuronal activity propagates through cortical networks, generating massive calcium influx. We previously showed that this activity could be triggered by brief stimulation of muscarinic receptors. Here, we show, by monitoring large cortical areas at low magnification, that although all areas respond to muscarinic agonists to some extent, only some areas are likely to generate the coordinated wave-like activation. The waves can be triggered repeatedly in frontal areas where, as we also show, waves occur spontaneously at a low frequency. In parietal and occipital areas, no such waves are seen. This selectivity may be related in part to differences in the cortical distribution of dopaminergic signaling, because we find that activation of dopamine receptors enables the response. Because M1 muscarinic receptors are typically coupled with G-alpha(q)/11, we investigated whether other receptors known to couple with this G-protein (group I glutamate metabotropic receptors, neurotensin type 1) could similarly elicit wave-like activation in responsive cortical areas. Our results suggest that multiple neurotransmitter systems can enable this form of activation in the frontal cortex. The findings suggest that a poorly recognized, developmentally regulated form of strong network activation found predominantly in the frontal cortex could potentially exert a profound influence on brain development.
Calderon
D Paola
DP
Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Leverkova
Natalya
N
Peinado
Alejandro
A
D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D020013:Calcium Signaling / Q000187:drug effects / Q000502:physiology*; D004298:Dopamine / Q000502:physiology; D005625:Frontal Lobe / Q000254:growth & development / Q000502:physiology*; D043802:GTP-Binding Protein alpha Subunits, Gq-G11 / Q000187:drug effects / Q000502:physiology*; D018698:Glutamic Acid / Q000494:pharmacology; D007189:Indans / Q000494:pharmacology; D009116:Muscarine / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000502:physiology*; D009496:Neurotensin / Q000494:pharmacology; D009778:Occipital Lobe / Q000254:growth & development; D010296:Parietal Lobe / Q000254:growth & development; D010446:Peptide Fragments / Q000494:pharmacology; D010617:Phenanthridines / Q000494:pharmacology; D010852:Picrotoxin / Q000494:pharmacology; D051381:Rats; D020318:Rats, Long-Evans; D017208:Rats, Wistar; D064529:Receptor, Metabotropic Glutamate 5; D043643:Receptor, Muscarinic M1 / Q000187:drug effects / Q000502:physiology; D043587:Receptor, Muscarinic M3 / Q000187:drug effects / Q000502:physiology; D017447:Receptors, Dopamine D1 / Q000187:drug effects / Q000502:physiology; D018094:Receptors, Metabotropic Glutamate / Q000037:antagonists & inhibitors
D000109:Acetylcholine; D001552:Benzazepines; D004298:Dopamine; D043802:GTP-Binding Protein alpha Subunits, Gq-G11; D018698:Glutamic Acid; D007189:Indans; D009116:Muscarine; D009419:Nerve Tissue Proteins; D009496:Neurotensin; D010446:Peptide Fragments; D010617:Phenanthridines; D010852:Picrotoxin; D064529:Receptor, Metabotropic Glutamate 5; D043643:Receptor, Muscarinic M1; D043587:Receptor, Muscarinic M3; D017447:Receptors, Dopamine D1; D018094:Receptors, Metabotropic Glutamate; C095756:1-aminoindan-1,5-dicarboxylic acid; C042090:neuromedin N; C061532:dihydrexidine; C054381:neurotensin (8-13)
Nat Neurosci. 2001 Nov;4 Suppl:1207-14
11687831
J Physiol. 1989 Sep;416:303-25
2575165
Mol Pharmacol. 1995 Dec;48(6):988-94
8848015
J Neurosci. 1988 Dec;8(12):4653-61
3199199
J Comp Neurol. 1993 Nov 1;337(1):168-75
7506271
J Neurophysiol. 1991 Feb;65(2):247-63
1673153
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12144-9
10518590
Trends Pharmacol Sci. 1999 Jul;20(7):302-9
10390649
Science. 1999 Jul 23;285(5427):599-604
10417392
J Comp Neurol. 1996 Nov 11;375(2):289-302
8915831
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13481-6
8942960
Brain Res. 1982 Oct;281(2):222-8
6754007
J Biol Chem. 2001 Sep 21;276(38):35900-8
11461909
Science. 1998 Mar 27;279(5359):2108-12
9516112
Neuroscience. 1988 Apr;25(1):307-17
2839800
J Neurosci. 2000 Jan 15;20(2):RC54
10632620
Nature. 2004 Jun 3;429(6991):523-30
15175743
J Neurosci. 1995 Dec;15(12):7916-28
8613730
J Neurosci. 1996 Dec 1;16(23):7619-26
8922418
Cereb Cortex. 2000 Mar;10(3):206-19
10731217
Trends Neurosci. 2001 Jun;24(6):353-60
11356508
Nat Neurosci. 2000 May;3(5):452-9
10769384
Cell. 1993 Jan;72 Suppl:77-98
8428376
Synapse. 2004 Jan;51(1):32-58
14579424
Neurosci Lett. 2001 May 11;303(3):141-4
11323105
J Comp Neurol. 1988 Mar 1;269(1):58-72
3361004
Nature. 1995 Jun 29;375(6534):784-7
7596410
Brain Res. 1982 Sep;281(1):41-52
6182953
J Neurosci. 1998 Jan 1;18(1):294-306
9412508
Curr Opin Neurobiol. 1999 Feb;9(1):94-104
10072366
Curr Opin Neurobiol. 1999 Feb;9(1):88-93
10072369
J Neurobiol. 1999 Oct;41(1):33-43
10504190
J Pharmacol Exp Ther. 1990 Jun;253(3):987-92
1972756
Neuron. 1999 Apr;22(4):653-6
10230785
Science. 1991 Feb 22;251(4996):947-50
1825731
Nature. 1982 Oct 14;299(5884):583-91
6811951
J Neurophysiol. 2001 Feb;85(2):620-9
11160498
Science. 2000 Mar 3;287(5458):1660-4
10698743
Cereb Cortex. 2003 Apr;13(4):409-21
12631570
J Physiol. 1998 Feb 15;507 ( Pt 1):219-36
9490842
Annu Rev Neurosci. 1999;22:29-47
10202531
Cereb Cortex. 2002 Jun;12(6):625-38
12003862
Nature. 2002 Nov 14;420(6912):173-8
12432392
Science. 1996 Nov 15;274(5290):1133-8
8895456
Mol Cell Neurosci. 2000 Oct;16(4):376-87
11085875
Nat Neurosci. 2001 Aug;4(8):803-12
11477426
Neuron. 1995 Mar;14(3):477-85
7695894
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):602-8
8570602
Prog Brain Res. 2004;145:131-42
14650912
Neuroscience. 1987 Jun;21(3):807-24
3627435
Brain Res Dev Brain Res. 1999 Mar 12;113(1-2):115-31
10064881
Neuron. 2004 May 27;42(4):553-66
15157418
Science. 1995 Apr 14;268(5208):239-47
7716515
Brain Res Dev Brain Res. 2002 Jan 31;133(1):69-75
11850065
Nat Neurosci. 2001 Feb;4(2):184-93
11175880
J Physiol Paris. 2002 Jan-Mar;96(1-2):73-80
11755785
Science. 2002 Jun 14;296(5575):2049-52
12065842
J Neurosci. 1996 Oct 15;16(20):6414-23
8815920
Nat Neurosci. 2000 Oct;3(10):1027-34
11017176
J Comp Neurol. 1982 Jun 20;208(2):177-95
7119156
Nat Neurosci. 2000 Nov;3 Suppl:1184-91
11127836
Brain Res Dev Brain Res. 1989 May 1;47(1):123-8
2567641
J Neurosci. 1999 Apr 15;19(8):3007-22
10191318
Science. 1992 Jul 31;257(5070):665-9
1496379
Science. 1991 May 17;252(5008):939-43
2035024
Cereb Cortex. 1997 Oct-Nov;7(7):619-34
9373018
Neuron. 2002 Jan 31;33(3):357-67
11832224
Eur J Neurosci. 1995 May 1;7(5):1050-63
7613610
Brain Res. 1994 May 9;645(1-2):113-22
7914812
J Pharmacol Exp Ther. 1997 May;281(2):721-9
9152378
J Comp Neurol. 1978 Jul 1;180(1):59-71
649789
J Neurosci. 1998 Jul 15;18(14):5180-90
9651201